Список литературы

Поставить закладку

Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney Int Suppl 2012; №2: 1–126.
Langenberg C, Wan L, Egi M, May CN, Bellomo R. Renal blood flow in experimental septic acute renal failure. Kidney Int. 2006; № 69 (11): 1996-2002
Zhang Q, Raoof M, Chen Y, et al. Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature 2010; №464 (7285):104-107.
Bosmann M, Ward PA. The inflammatory response in sepsis. Trends Immunol. 2013; №34 (3):129-136.
Linkermann A, Green DR. Necroptosis. N. Engl. J. Med. 2014; №370 (5):455-465.
Goldstein SL. Medication-induced acute kidney injury. Curr Opin Crit Care. 2016; №22 (6):542-545
Wang H.E., Muntner P., Chertow G.M. et al. Acute Kidney Injury and Mortality in Hospitalized Patients. Am J Nephrol. 2012; №35: 349–355.
Brown JR, Rezaee ME, Marshall EJ, et al. Hospital Mortality in the United States following Acute Kidney Injury. Biomed Res Int. 2016; 2016:4278579.
Susantitaphong P, Cruz DN, Cerda J, et al. World incidence of AKI: a meta-analysis. Clin J Am Soc Nephrol. 2013; №8 (9): 1482-1493.
Chertow G.M., Burdick E., Honour M. et al. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol. 2005; №16: 3365-3370.
Claure-Del Granado R1, Bouchard J. Acid-base and electrolyte abnormalities during renal support for acute kidney injury: recognition and management. Blood Purif. 2012; №34 (2):186-93.
Perazella MA, Coca SG, Hall IE, et al. Urine Microscopy Is Associated with Severity and Worsening of Acute Kidney Injury in Hospitalized Patients. Clinical Journal of the American Society of Nephrology ; 2010; № 5(3): 402-408.
Bagshaw SM, Haase M, Haase-Fielitz A, et al. A prospective evaluation of urine microscopy in septic and non-septic acute kidney injury. Nephrol Dial Transplant; 2012; №27(2): 582-8
Nguyen TC, Cruz MA, Carcillo JA. Thrombocytopenia-Associated Multiple Organ Failure and Acute Kidney Injury. Crit Care Clin. 2015; №31(4): 661-74
De Santo L, Romano G, Della Corte A, et al. Preoperative anemia in patients undergoing coronary artery bypass grafting predicts acute kidney injury. J Thorac Cardiovasc Surg. 2009; №138(4): 965-70.
Li Y, Tang X, Zhang J, et al. Nutritional support for acute kidney injury. Cochrane Database Syst Rev. 2010; (1):CD005426.
Satirapoj B, Kongthaworn S, Choovichian P Electrolyte disturbances and risk factors of acute kidney injury patients receiving dialysis in exertional heat stroke. BMC Nephrol. 2016; №17(1): 55.
Allegretti AS, Ortiz G, Wenger J, et al.Prognosis of Acute Kidney Injury and Hepatorenal Syndrome in Patients with Cirrhosis: A Prospective Cohort Study. Int J Nephrol. 2015; 2015: 108139.
Safari S, Yousefifard M, Hashemi B, et al. The value of serum creatine kinase in predicting the risk of rhabdomyolysis-induced acute kidney injury: a systematic review and meta-analysis. Clin Exp Nephrol. 2016; №20(2): 153-61
Premru V, Kovač J, Ponikvar R. Use of myoglobin as a marker and predictor in myoglobinuric acute kidney injury. Ther Apher Dial 2013; №17(4): 391-5.
Petejova N, Martinek A. Acute kidney injury due to rhabdomyolysis and renal replacement therapy: a critical review. Crit Care. 2014; №18(3): 224
Faubel S, Patel NU, Lockhart ME, Cadnapaphornchai MA. Renal relevant radiology: use of ultrasonography in patients with AKI. Clin J Am Soc Nephrol. 2014; №9: 382–94.
Asfar P, Meziani F, Hamel JF, et al. High versus low blood-pressure target in patients with septic shock. N Engl J Med 2014; №370: 1583–93.
Poukkanen M, Wilkman E, Vaara ST, et al. Hemodynamic variables and progression of acute kidney injury in critically ill patients with severe sepsis: data from the prospective observational FINNAKI study. Crit Care 2013; №17: R295.
Walsh M, Devereaux PJ, Garg AX, et al. Relationship between intraoperative mean arterial pressure and clinical outcomes after noncardiac surgery: toward an empirical definition of hypotension. Anesthesiology 2013; №119: 507–15.
Jacobs FM. Relation between mean arterial pressure and renal function in the early phase of shock: a prospective, explorative cohort study. Crit Care 2011; №15 (5): 442.
Annane D, Siami S, Jaber S, et al. Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial. JAMA 2013; №310: 1809–17.
Myburgh JA, Finfer S, Bellomo R, et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med 2012; №367: 1901–11.
Prowle J.R., Bellomo R. Fluid administration and the kidney. Curr Opin Crit Care 2013; №19: 308-314.
Lira A, Pinsky MR. Choices in fluid type and volume during resuscitation: impact on patient outcomes. Ann Intensive Care2014; №4: 38.
Perel P, Roberts I, Ker K. Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev.2013; (2): CD000567.
Ichai C, Vinsonneau C, Souweine B, et al. Acute kidney injury in the perioperative period and in intensive care units (excluding renal replacement therapies). Ann Intensive Care. 2016; №6 (1) :48
McCluskey SA, Karkouti K, Wijeysundera D, et al. Hyperchloremia after non-cardiac surgery is independently associated with increased morbidity and mortality: a propensity-matched cohort study. Anesth Analg 2013; №13: 412–21.
Yunos NM, Bellomo R, Hegarty C, et al. Association between a chloride-liberal vs chloride-restrictive intravenous fluid administration strategy and kidney injury in critically ill adults. JAMA 2012; №308: 1566–72.
Chowdhury AH, Cox EF, Francis ST, Lobo DN. A randomized, controlled, double-blind crossover study on the effects of 2-L infusions of 0.9% saline and plasma-lyte1 148 on renal blood flow velocity and renal cortical tissue perfusion in healthy volunteers. Ann Surg 2012; №256: 18–24.
Shaw AD, Bagshaw SM, Goldstein SL, et al. Major complications, mortality, and resource utilization after open abdominal surgery: 0.9% saline compared to Plasma-Lyte. Ann Surg 2012; №255: 821–9.
Payen D, de Pont AC, Sakr Y, et al. A positive fluid balance is associated with a worse outcome in patients with acute renal failure. Crit Care 2008; №12: R74.
Teixeira C, Garzotto F, Piccinni P, et al. Fluid balance and urine volume are independent predictors of mortality in acute kidney injury. Crit Care 2013; №17: R14.
Grams ME, Estrella MM, Coresh J, Brower RG, Liu KD. Fluid balance, diuretic use, and mortality in acute kidney injury. Clin J Am Soc Nephrol 2011; №6: 966–73.
Bellomo R, Cass A, Cole L, et al. An observational study fluid balance and patient outcomes in the randomized evaluation of normal vs. augmented level of replacement therapy trial. Crit Care Med 2012; №40: 1753–60.
Garzotto F, Ostermann M, Martín-Langerwerf D, et al. The Dose Response Multicentre Investigation on Fluid Assessment (DoReMIFA) in critically ill patients. Crit Care.2016; №20 (1): 196.
De Backer D, Biston P, Devriendt J, et al., SOAP II Investigators. Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med 2010; №362: 779–789
Rui Q, Jiang Y, Chen M et al. Dopamine versus norepinephrine in the treatment of cardiogenic shock: A PRISMA-compliant meta-analysis. Medicine (Baltimore). 2017; №96 (43): e8402.
Rhodes A., Evans L.E., Alhazzani W., et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Intensive Care Med. 2017; №43 (3): 304-377.
Schetz M., Vanhorebeek I., Wouters P.J., et al. Tight Blood Glucose Control Is Renoprotective in Critically Ill Patients. J Am Soc Nephrol. 2008; №19 (3): 571–578.
Krinsley J.S., Egi M., Kiss A., et al. Diabetic status and the relationship of the 3 domains of glycemic control to mortality in critically ill patients: an international multi-center cohort study. Crit Care 2013; №17: R37.
Cano N., Fiaccadori E., Tesinsky P., et al. ESPEN guidelines on enteral nutrition: Adult renal failure. Clin. Nutr. 2006; №25: 295–310.
Cano N, Aparicio M, Brunori G, Carrero JJ, Cianciaruso B, Fiaccadori E, et al. ESPEN guidelines on parenteral nutrition: adult renal failure. Clin Nutr 2009; №28: 401–14.
Fiaccadori E., Regolisti G., Cabassi A. Specific nutritional problems in acute kidney injury, treated with non-dialysis and dialytic modalities. NDT Plus 2010; №3 (1): 1–7.
Fiaccadori E., Maggiore U., Rotelli C., et al. Effects of different energy intakes on nitrogen balance in patients with acute renal failure: a pilot study. Nephrol Dial Transplant 2005; №20: 1976-1980.
Fiaccadori E., Lombardi M., Leonardi S., et al. Prevalence and clinical outcome associated with preexisting malnutrition in acute renal failure: a prospective cohort study. J Am Soc Nephrol. 1999; №10: 581-593.
Druml W. Nutritional management of acute renal failure. J Ren Nutr.2005; №15 (1): 63-70.
Kreymann K.G.; Berger M.M.; Deutz N.E.; et al. ESPEN guidelines on enteral nutrition: Intensive care. Clin. Nutr. 2006; №25: 210–223.
Blaser A. R., Starkopf J., Alhazzani W, et al. and ESICM Working Group on Gastrointestinal Function. Early enteral nutrition in critically ill patients: ESICM clinical practice guidelines. Intensive Care Med 2017; №43: 380–398.
Fiaccadori E., Regolisti G., Maggiore U. Specialized nutritional support interventions in critically ill patients on renal replacement therapy. Curr Opin Clin Nutr Metab Care. 2013; №16 (2): 217-24.
Berger MM, Shenkin A, Revelly JP, et al. Copper, selenium, zinc, and thiamine balances during continuous venovenous hemodiafiltration in critically ill patients. Am J Clin Nutr 2004; №80: 410–416
Ho K.M., Power B.M. Benefits and risks of furosemide in acute kidney injury. Anaesth.2010; №.65: 283–293.
Van der Voort P.H., Boerma E.C., Koopmans M. et al. Furosemide does not improve renal recovery after hemofiltration for acute renal failure in critically ill patients: a double blind randomized controlled trial Crit Care Med.2009; №37:533–538.
Grams ME, Estrella MM, Coresh J, Brower RG, Liu KD. Fluid balance, diuretic use, and mortality in acute kidney injury. Clin J Am Soc Nephrol 2011; №6: 966–73.
Bagshaw SM, Gibney RTN, Kruger P, et al. The effect of low-dose furosemide in critically ill patients with early acute kidney injury: A pilot randomized blinded controlled trial (the SPARK study) J Crit Care.2017; №42: 138-146.
Haase M, Fielitz AH, Plass M, et al. Prophylactic perioperative sodium bicarbonate to prevent acute kidney injury following open heart surgery: a multicenter double-blinded randomized controlled trial. Plos One 2013; 10: e1001426.
Hewitt J, Uniacke M, Hansi NK, et al. Sodium bicarbonate supplements for treating acute kidney injury. Cochrane Database Syst Rev 2012;№6 :CD009204.
Tie HT, Luo MZ, Luo MJ, et al. Sodium bicarbonate in the prevention of cardiac surgery-associated acute kidney injury: a systematic review and meta-analysis. Crit Care. 2014; №18 (5): 517.
Friedrich J.O., Adhikari N., Herridge M.S., Beyene J. Meta-analysis: low-dose dopamine increases urine output but does not prevent renal dysfunction or death. Ann Intern Med.2005; №142: 510-524.
Kellum JA, Decker MJ. Use of dopamine in acute renal failure: a metaanalysis. Crit Care Med 2001; №29: 1526–31.
Joannidis M, Druml W, Forni LG, et al. Prevention of acute kidney injury and protection of renal function in the intensive care unit: update 2017: Expert opinion of the Working Group on Prevention, AKI section, European Society of Intensive Care Medicine. Intensive Care Med. 2017; №43 (6): 730-749.
Chen X, Huang T, Cao X, et al. Comparative Efficacy of Drugs for Preventing Acute Kidney Injury after Cardiac Surgery: A Network Meta-Analysis. Am J Cardiovasc Drugs.2018; №18 (1): 49-58.
Yang B, Xu J, Xu F, et al. Intravascular administration of mannitol for acute kidney injury prevention: a systematic review and meta-analysis. PLoS One. 2014; №9 (1): e85029.
Bove T, Matteazzi A, Belletti A, et al. Beneficial impact of levosimendan in critically ill patients with or at risk for acute renal failure: a meta-analysis of randomized clinical trials. Heart Lung Vessel 2015; №7: 35–46
Gordon AC, Perkins GD, Singer M, et al. Levosimendan for the prevention of acute organ dysfunction in sepsis. N Engl J Med 2016; №375:1638–1648.
Mehta RH, Leimberger JD, van Diepen S, et al., LEVO-CTS Investigators Levosimendan in patients with left ventricular dysfunction undergoing cardiac surgery. N Engl J Med. 2017; №376 (21): 2032-2042.
Landoni G, Lomivorotov VV, Alvaro G, et al. CHEETAH Study Group Levosimendan for hemodynamic support after cardiac surgery. N Engl J Med. 2017; №376 (21): 2021-2031.
Endre ZH, Walker RJ, Pickering JW, et al. Early intervention with erythropoietin does not affect the outcome of acute kidney injury (the EARLYARF trial). Kidney Int 2010; №77: 1020–1030.
Zhao C, Lin Z, Luo Q, et al. Efficacy and safety of erythropoietin to prevent acute kidney injury in patients with critical illness or perioperative care: a systematic review and meta-analysis of randomized controlled trials. J Cardiovasc Pharmacol 2015; №65: 593–600.
Song YR, Lee T, You SJ, et al. Prevention of acute kidney injury by erythropoietin in patients undergoing coronary artery bypass grafting: a pilot study. Am J Nephrol 2009; №30: 253–260
de Seigneux S, Ponte B, Weiss L, et al. Epoetin administrated after cardiac surgery: effects on renal function and inflammation in a randomized controlled study. BMC Nephrol 2012; №13: 132
Wargo KA, Edwards J. Aminoglycoside-induced nephrotoxicity. J Pharm Pract 2014; №27: 573–7.
Picard W, Bazin F, Clouzeau B, et al. Propensity-based study of aminoglycoside nephrotoxicity in patients with severe sepsis or septic shock. Antimicrob Agents Chemother 2014; №58: 7468–74.
Ehrmann S, Quartin A, Hobbs BP et al. Contrast-associated acute kidney injury in the critically ill: systematic review and Bayesian meta-analysis. Intensive Care Med. 2017; №43(6): 785-794
Wilhelm-Leen E, Montez-Rath ME, Chertow G Estimating the risk of radiocontrast-associated nephropathy. J Am Soc Nephrol 2017; №28: 653–659
McDonald JS, McDonald RJ, Williamson EE, et al. Post-contrast acute kidney injury in intensive care unit patients: a propensity score-adjusted study. Intensive Care Med.2017; №43 (6): 774-784.
Sun Z, Fu Q, Cao L, et al. Intravenous N-acetylcysteine for prevention of contrast-induced nephropathy: a metaanalysis of randomized, controlled trials. PLoS One 2013; №8: e55124.
ACT Investigators Acetylcysteine for prevention of renal outcomes in patients undergoing coronary and peripheral vascular angiography: main results from the randomized Acetylcysteine for Contrast-induced nephropathy Trial (ACT). Circulation 2011; №124:1250–1259.
Xu R1, Tao A1, Bai Y2, et al. Effectiveness of N-Acetylcysteine for the Prevention of Contrast-Induced Nephropathy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. J Am Heart Assoc. 2016; №5 (9): e003968.
Sandilands EA, Bateman DN Adverse reactions associated with acetylcysteine. Clin Toxicol (Phila) 2009; №47:81–88.
Nijssen EC, Rennenberg RJ, Nelemans PJ, et al. Prophylactic hydration to protect renal function from intravascular iodinated contrast material in patients at high risk of contrast-induced nephropathy (AMACING): a prospective, randomised, phase 3, controlled, open-label, non-inferiority trial. Lancet 2017; №389: 1312–1322.
Merten GJ, Burgess WP, Gray LV, et al. Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial. JAMA 2004; №291: 2328–2334.
Ozcan EE, Guneri S, Akdeniz B et al. Sodium bicarbonate, N-acetylcysteine, and saline for prevention of radiocontrast-induced nephropathy. A comparison of 3 regimens for protecting contrast-induced nephropathy in patients undergoing coronary procedures. A single-center prospective controlled trial. Am Heart J 2007; №154: 539–544.
Liu Y, Li H, Chen S, Chen J, et al. Excessively high hydration volume may not be associated with decreased risk of contrast-induced acute kidney injury after percutaneous coronary intervention in patients with renal insufficiency. J Am Heart Assoc. 2016; №5: e003171.
Ostermann M, Joannidis M, Pani A, et al. Patient Selection and Timing of Continuous Renal Replacement Therapy. 17th Acute Disease Quality Initiative (ADQI) Consensus Group. Blood Purif. 2016; №42(3): 224-37
Bagshaw SM, Cruz DN, Gibney RT, et al. A proposed algorithm for initiation of renal replacement therapy in adult critically ill patients. Crit Care. 2009; №13(6): 317.
Annigeri RA, Ostermann M, Tolwani A, et al. Renal Support for Acute Kidney Injury in the Developing World. Kidney International Reports 2017; №2: 559–578
Bagshaw SM, Wald R. Indications and Timing of Continuous Renal Replacement Therapy Application. Contrib Nephrol. 2018; №194: 25-37
Teixeira C, Garzotto F, Piccinni P, et al. NEFROINT investigators. Fluid balance and urine volume are independent predictors of mortality in acute kidney injury. Crit Care. 2013; №17(1): R14
Gibney N, Hoste E, Burdmann EA, et al. Timing of initiation and discontinuation of renal replacement therapy in AKI: unanswered key questions. Clin J Am Soc Nephrol 2008, №3: 876-880.
Joannidis M, Forni LG: Clinical review: timing of renal replacement therapy. Crit Care 2011; 15: 223.
F. P. Wilson, W. Yang,C.A. Machado, et al. Dialysis versus Nondialysis in Patients with AKI: A Propensity-Matched Cohort Study. Clin J Am Soc Nephrol.2014; №9: 673–681
Karvellas C.J., Farhat M.R., Sajjad I. et al. A comparison of early versus late initiation of renal replacement therapy in critically ill patients with acute kidney injury: a systematic review and meta-analysis. Critical Care. 2011; №15: 72.
Wald R, Adhikari NK, Smith OM, et al. Comparison of standard and accelerated initiation of renal replacement therapy in acute kidney injury. Kidney Int. 2015; №88(4): 897-904.
Zarbock A, Kellum JA, Schmidt C, et al. Effect of Early vs Delayed Initiation of Renal Replacement Therapy on Mortality in Critically Ill Patients With Acute Kidney Injury: The ELAIN Randomized Clinical Trial. JAMA 2016; №315(20): 2190-9.
Gaudry S, Hajage D, Schortgen F, et al. Initiation Strategies for Renal-Replacement Therapy in the Intensive Care Unit. N Engl J Med. 2016; №375(2): 122-33.
Xiao-mei Yang, Guo-wei Tu, Ji-li Zheng, et al. A comparison of early versus late initiation of renal replacement therapy for acute kidney injury in critically ill patients: an updated systematic review and metaanalysis of randomized controlled trials. BMC Nephrology 2017; №18: 264
Clark E, Wald R, Levin A, et al. Timing the initiation of renal replacement therapy for acute kidney injury in Canadian intensive care units: a multicentre observational study. Can J Anaesth.2012; №59 (9): 861-70.
Ronco C, Bellomo R, Brendolan A, et al. Brain density changes during renal replacement in critically ill patients with acute renal failure. Continuous hemofiltration versus intermittent hemodialysis. J Nephrol. 1999; №12: 173–178.
Miyazawa H, Ookawara S, Tabei K. Aggravation of cerebral oxygenation due to intradialytic hypotension induced by blood volume reduction during hemodialysis: a case report. Ther Apher Dial. 2015; №19: 525–527.
Ko SB, Choi HA, Gilmore E, et al. Pearls & Oysters: the effects of renal replacement therapy on cerebral autoregulation. Neurology. 2012; №78:e36–e38.
Bagshaw S.M., Berthiaume L.R., Delaney A. et al. Continuous versus intermittent renal re-placement therapy for critically ill patients with acute kidney injury: a meta-analysis. Crit Care Med. 2008; №36: 610–617.
Ghahramani N., Shadrou S., Hollenbeak C. A systematic review of continuous renal re-placement therapy and intermittent haemodialysis in management of patients with acute renal failure. Nephrol (Carlton). 2008; №13: 570-578.
Rabindranath K., Adams J., Macleod A.M. et al. Intermittent versus continuous renal replacement therapy for acute renal failure in adults. Cochrane Database Syst Rev. 2007; №18: CD003773
Nash DM, Przech S, Wald R et al. Systematic review and meta-analysis of renal replacement therapy modalities for acute kidney injury in the intensive care unit. J Crit Care. 2017;№41: 138-144
Ричи З. и Ронко К. Руководство по экстракорпоральному очищению крови в интенсивной терапии Под редакцией: Л.А. Бокерия, М.Б. Ярустовского: М.2016; с. 400-420
Zhang L, Yang J, Eastwood GM, et al. Extended Daily Dialysis Versus Continuous Renal Replacement Therapy for Acute Kidney Injury: A Meta-analysis. // Am J Kidney Dis.-2015.-Vol.66.-№2.-Р.322-30.
Schneider AG1, Bellomo R, Bagshaw SM, et al. Choice of renal replacement therapy modality and dialysis dependence after acute kidney injury: a systematic review and meta-analysis. Intensive Care Med. 2013; №39 (6): 987-97.
Liang KV, Sileanu FE, Clermont G et al. Modality of RRT and Recovery of Kidney Function after AKI in Patients Surviving to Hospital Discharge. Clin J Am Soc Nephrol. 2016; №11 (1): 30-8.
Jan O Friedrich, Ron Wald, Sean M Bagshaw, et al. Hemofiltration compared to hemodialysis for acute kidney injury: systematic review and meta-analysis. Critical Care. 2012; №16: R146
Ronco C, Ricci Z, De Backer D , et al. Renal replacement therapy in acute kidney injury: controversy and consensus. Crit Care. 2015; №19: 146.
Ricci Z, Ronco C. Pre- versus post-dilution CVVH. Blood Purif 2005; №23: 338.
Tian JH, Ma B, Yang K, et al. Bicarbonate- versus lactate-buffered solutions for acute continuous haemodiafiltration or haemofiltration. Cochrane Database Syst Rev. 2015; №5 (3): CD006819.
Palevsky P.M., Zhang J.H., O’Connor T.Z. et al. Intensity of renal support in critically ill patients with acute kidney injury N Engl J Med. 2008; №359: 7–20.
Bellomo R., Cass A., Cole L. et al. Intensity of continuous renal-replacement therapy in critically ill patients. N Engl J Med. 2009; №361: 1627–1638.
Joannes-Boyau O, Honoré PM, Perez P, et al. High-volume versus standard-volume haemofiltration for septic shock patients with acute kidney injury (IVOIRE study): a multicentre randomized controlled trial. Intensive Care Med.2013; №39 (9): 1535-46.
Clark E, Molnar AO, Joannes-Boyau O, et al. High-volume hemofiltration for septic acute kidney injury: a systematic review and meta-analysis. Crit Care.2014; №18 (1): R7.
Combes A, Bréchot N, Amour J, et al. Early High-Volume Hemofiltration versus Standard Care for Post-Cardiac Surgery Shock. The HEROICS Study. Am J Respir Crit Care Med. 2015; №192(10): 1179-1190.
Fischer KG. Essentials of anticoagulation in hemodialysis. Hemodial Int 2007; №11: 178–189.
Ouseph R, Ward RA. Anticoagulation for intermittent hemodialysis. Semin Dial 2000; №13: 181–187.
Liu C, Mao Z, Kang H, et al. Regional citrate versus heparin anticoagulation for continuous renal replacement therapy in critically ill patients: a meta-analysis with trial sequential analysis of randomized controlled trials. Crit Care. 2016; №20: 144.
Oudemans-van Straaten HM, Wester JP, de Pont AC, Schetz MR. Anticoagulation strategies in continuous renal replacement therapy: can the choice be evidence based? Intensive Care Med. 2006; №32: 188–202.
Joannidis M, Kountchev J, Rauchenzauner M, et al. Enoxaparin vs. unfractionated heparin for anticoagulation during continuous veno-venous hemofiltration: a randomized controlled crossover study. Intensive Care Med. 2007; 33: 1571–9.
Parienti JJ, Thirion M, Megarbane B, et al. Femoral vs jugular venous catheterization and risk of nosocomial events in adults requiring acute renal replacement therapy: a randomized controlled trial. JAMA. 2008; №299: 2413–2422.
Bellomo R, Martensson J, Lo S, et al. Femoral access and delivery of continuous renal replacement therapy dose. Blood Purif. 2016; 41: 11–17.
Parienti JJ, Megarbane B, Fischer MO, et al. Catheter dysfunction and dialysis performance according to vascular access among 736 critically ill adults requiring renal replacement therapy: a randomized controlled study. Crit Care Med. 2010; №38: 1118–25.
Rabindranath KS, Kumar E, Shail R, et al. Ultrasound use for the placement of haemodialysis catheters. Cochrane Database Syst Rev. 2011; №58: CD005279.
Uchino S, Bellomo R, Morimatsu H, I, et al. Discontinuation of continuous renal replacement therapy: a post hoc analysis of a prospective multicenter observational study. Crit Care Med. 2009; №37: 2576–82.
An Zhang, Ying Cai, Peng-Fei Wang, et al. Diagnosis and prognosis of neutrophil gelatinase-associated lipocalin for acute kidney injury with sepsis: a systematic review and meta-analysis. Crit Care 2016; №20: 41
Ho J, Tangri N, Komenda P, et al. Urinary, Plasma, and Serum Biomarkers' Utility for Predicting Acute Kidney Injury Associated With Cardiac Surgery in Adults: A Meta-analysis. Am J Kidney Dis. 2015; № 66 (6): 993-1005.
Hilde R.H., de Geus D., Betjes M.G., Bakker J. Biomarkers for the prediction of acute kidney injury: a narrative review on current status and future challenges. Clin Kidney J. 2012; №5: 102–108